Dr. Kessler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3801 N Lamar Blvd
300
Austin, TX 78756Phone+1 512-421-3869Fax+1 512-407-1881
Education & Training
University of Texas Southwestern Medical CenterFellowship, Clinical Cardiac Electrophysiology, 1994 - 1996- University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1991 - 1994
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1989 - 1991
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1989
Certifications & Licensure
TX State Medical License 1990 - 2026
CO State Medical License 2017 - 2025- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 72 citationsEffects of repeated electrical defibrillations on cardiac troponin I levels.Jose A. Joglar, David J. Kessler, Patrick J Welch, Joseph H. Keffer, Michael E. Jessen
The American Journal of Cardiology. 1999-01-15 - 30 citationsAblation of Ventricular Tachycardia Associated with Tetralogy of Fallot: Demonstration of Bidirectional BlockRodney P. Horton, Robert C. Canby, David J. Kessler, Jose A. Joglar, Andrew Hume
Journal of Cardiovascular Electrophysiology. 1997-04-01 - 10 citationsSelective radiofrequency ablation of the “slow” atrioventricular nodal pathway for control of the ventricular response to atrial fibrillation☆Robert C. Canby, Carlos A. Román, David J. Kessler, Rodney P. Horton, Richard L. Page
The American Journal of Cardiology. 1996-06-15
Press Mentions
Why Do We Pair a Capable Health Care System with a Nonsensical Way of Paying for It?October 7th, 2022- FDA Considers Limiting Authorization of Certain Monoclonal Antibody TreatmentsJanuary 22nd, 2022
- Q&A: Tillman Gerngross Explains Why His Covid mAb Will Have an Edge over an Already Crowded FieldOctober 15th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
